Logo image
Off-Label Use of Ondansetron in Pregnancy in Western Australia
Journal article   Open access   Peer reviewed

Off-Label Use of Ondansetron in Pregnancy in Western Australia

Lyn Colvin, Andrew W. Gill, Linda Slack-Smith, Fiona J. Stanley and Carol Bower
BioMed research international, Vol.2013, 909860
2013
PMCID: PMC3874333
PMID: 24396830
pdf
Published613.52 kBDownloadView
Published (Version of Record)CC BY V4.0 Open Access

Abstract

Aims Nausea and vomiting of pregnancy is the most common medical condition in pregnancy. There is an increasing trend to prescribe ondansetron although its safety for use in pregnancy has not been established. Methods. Exposed pregnancies were all births in Western Australia, 2002–2005, where the mother was dispensed ondansetron under the Australian Pharmaceutical Benefits Scheme, compared with all other births during the same period. Outcomes investigated include maternal and child characteristics, birth defects, pregnancy, and delivery characteristics. Results There were 96,968 births from 2002 to 2005. Ondansetron was dispensed to 251 pregnant women during this period. The women dispensed ondansetron were more likely to be privately insured (OR: 5.8; 95% CI: 4.3–7.9), to be Caucasian (3.3; 1.9–5.7), not to smoke during their pregnancy (2.9; 1.8–4.7), to have a multiple birth (2.7; 1.5–5.0), and to have used fertility treatment (1.8; 1.0–3.4). There was a small but not significantly increased risk of a major birth defect with first trimester exposure (1.2; 0.6–2.2). Conclusions Our study did not detect any adverse outcomes from the use of ondansetron in pregnancy but could not conclude that ondansetron is safe to use in pregnancy.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being
#5 Gender Equality

Source: InCites

Metrics

1 File views/ downloads
35 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.72 Obstetrics & Gynecology
1.72.1745 Pregnancy Medication Safety
Web Of Science research areas
Biotechnology & Applied Microbiology
Medicine, Research & Experimental
ESI research areas
Biology & Biochemistry
Logo image